首页>
外国专利>
BIOMARKERS, USES OF BIOMARKERS AND A METHOD OF IDENTIFYING BIOMARKERS FOR COLORECTAL CARCINOMA (CRC) LIVER METASTASIS
BIOMARKERS, USES OF BIOMARKERS AND A METHOD OF IDENTIFYING BIOMARKERS FOR COLORECTAL CARCINOMA (CRC) LIVER METASTASIS
展开▼
机译:生物标志物,生物标志物的用途以及大肠癌转移的生物标志物识别方法
展开▼
页面导航
摘要
著录项
相似文献
摘要
The invention relates to the use of one or more of protein myoferlin, protein latent- transforming growth factor beta binding protein 2, protein transforming growth factor beta induced protein ig-h3, protein adipocyte enhancer-binding protein 1, protein EMILIN1,protein periostin, protein CD97, protein prolargin, protein Thy-1 membrane glycoprotein, protein growth hormone inducible transmembrane protein, protein biglycan, protein EPCAM and protein EMILIN2 as a biomarker for colorectal carcinoma (CRC) liver metastasis, or a predisposition thereto. The invention also relates to ligands directed to the above-mentioned biomarkers, for use in the therapeutic and/or prophylactic treatment of CRC liver metastasis.
展开▼